Cardiovascular education for people with rheumatoid arthritis: What can existing patient education programmes teach us?

Rheumatology

Volumn 50, Issue 10, 2011, Pages 1751-1759

  John, Holly ^a,b   Carroll, Douglas ^b   Kitas, George D ^a  

^a DUDLEY GROUP OF HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Cardiovascular disease; Patient education; Rheumatoid arthritis; Social cognition theory; Stages of change theory

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR EDUCATION; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; COCHRANE LIBRARY; EXERCISE; HUMAN; INTERVIEW; LIFESTYLE MODIFICATION; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; PATIENT COUNSELING; PATIENT EDUCATION; PRIMARY PREVENTION; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RHEUMATOID ARTHRITIS; SECONDARY PREVENTION; SELF CONCEPT; SYSTEMATIC REVIEW (TOPIC);

ARTHRITIS, RHEUMATOID; ATTITUDE TO HEALTH; CARDIOVASCULAR DISEASES; COGNITIVE THERAPY; HUMANS; PATIENT EDUCATION AS TOPIC; PROGRAM DEVELOPMENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 80053162880     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ker191     Document Type: Review

References (96)

1. Symmons DP. Looking back: rheumatoid arthritis-aetiology, occurrence and mortality. Rheumatology 2005; 44(Suppl. 4):iv14-17.
2. Treharne GJ, Lyons AC, Hale ED, Douglas KM, Kitas GD. 'Compliance' is futile but is 'concordance' between rheumatology patients and health professionals attainable? Rheumatology 2006;45:1-5.
3. Lorig K. Common sense patient education. Victoria, Australia: Fraser Publications, 1992.
4. Walker D, Adebajo A, Heslop P et al. Patient education in rheumatoid arthritis: the effectiveness of the ARC booklet and the mind map. Rheumatology 2007;46: 1593-6.
5. Hill J. A practical guide to patient education and information giving. Ballieres Clin Rheum 1997;11:109-27.
6. Lorig K, Ritter P, Stewart AL et al. Chronic disease self-management program: 2-year health status and health care utilization outcomes. Med Care 2001;39: 1217-23.
7. Barlow JH, Turner AP, Wright CC. A randomized controlled study of the Arthritis Self-Management Programme in the UK. Health Educ Res 2000;15:665-80.
8. Riemsma RP, Taal E, Kirwan JR, Rasker JJ. Systematic review of rheumatoid arthritis patient education. Arthritis Rheum 2004;51:1045-59.
9. Albano MG, Giraudet-Le Quintrec J-S, Crozet C, d'Ivernois J-F. Characteristics and development of therapeutic patient education in rheumatoid arthritis: analysis of the 2003-2008 literature. Joint Bone Spine 2010;77: 405-10.
10. Michaud K, Wolfe F. Comorbidities in rheumatoid arthritis. Best Pract Res Clin Rheumatol 2007;21:885-906.
11. Kitas GD, Erb N. Tackling ischaemic heart disease in rheumatoid arthritis. Rheumatology 2003;42:607-13.
12. Panoulas VF, Metsios G, Pace AV et al. Hypertension in rheumatoid arthritis. Rheumatology 2008;47:1286-98.
13. Toms TE, Symmons DP, Kitas GD. Dyslipidaemia in rheumatoid arthritis: the role of inflammation, drugs, lifestyle and genetic factors. Curr Vasc Pharmacol 2010;8: 301-26.
14. Stavropoulos-Kalinoglou A, Metsios G, Koutedakis Y, Kitas GD. Obesity in rheumatoid arthritis. Rheumatology. Epub 19 October 2010, doi:10.1093/rheumatology/keq266.
15. Metsios G, Stavropoulos-Kalinoglou A, Veldhuijzen van Zanten J et al. Rheumatoid arthritis, cardiovascular disease and physical exercise: a systematic review. Rheumatology 2008;47:239-48.
16. Stevens RJ, Douglas KM, Saratzis AN, Kitas GD. Inflammation and atherosclerosis in rheumatoid arthritis. Expert Rev Mol Med 2005;7:1-24.
17. Dessein PH, Joffe BI, Stanwix AE. Effects of disease modifying agents and dietary intervention on insulin resistance and dyslipidaemia in inflammatory arthritis: a pilot study. Arthritis Res 2002;4:R12.
18. John H, Kitas GD, Toms TE, Goodson N. Cardiovascular co-morbidity in rheumatoid arthritis. Best Pract Res Clin Rheumatol 2009;23:71-82.
19. del Rincon I, Freeman GL, Haas RW, O'Leary DH, Escalante A. Relative contributions of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis. Arthritis Rheum 2005;52: 3413-23.
20. Dessein PH, Joffe BI, Veller MG et al. Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis. J Rheumatol 2005;32:435-42.
21. Luqmani R, Hennell S.L., Estrach C et al. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years). Rheumatology 2009; 48:436-9.
22. Peters MJL, Symmons DPM, McCarey D et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 2010; 68:325-31.
23. Bell C, Rowe IF. The recognition and assessment of cardiovascular risk in primary care in people with Rheumatoid Arthritis: a questionnaire based study of General Practitioners. Musculoskeletal Care. Advance Access published March 5, 2010, doi:10.1002/msc.196.
24. John H, Hale ED, Treharne GJ, Kitas G. Patient education on cardiovascular aspects of rheumatoid disease: an unmet need. Rheumatology 2007;46:1513-6.
25. Astin JA, Beckner W, Soeken K, Hochberg MC, Berman B. Psychological interventions for rheumatoid arthritis: a meta-analysis of randomised controlled trials. Arthritis Care Res 2002;47:291-302.
26. Badamgarav E, Croft JD Jr, Hohlbaich A et al. Effects of disease management programs on functional status of patients with rheumatoid arthritis. Arthritis Rheum 2003; 49:377-87.
27. Niedermann K, Fransen J, Knols R, Uebelhart D. Gap between short- and long-term effects of patient education in rheumatoid arthritis patients: a systematic review. Arthritis Rheum 2004;51:388-98.
28. Christie A, Jamtvedt G, Dahm KT, Moe RH, Harvaardsholm EA, Hagen KB. Effectiveness of nonpharmacological and nonsurgical interventions for patients with rheumatoid arthritis: an overview of systematic reviews. Phys Ther 2007;87:1697-715.
29. Riemsma RP, Taal E, Rasker JJ. Group education for patients with rheumatoid arthritis and their partners. Arthritis Rheum 2003;49:556-66.
30. van Lankveld W, van Helmond T, Naring G, Jan de Rooij D, van der Hoogen F. Partner participation in cognitive-behavioural self-management group treatment for patients with rheumatoid arthritis. J Rheumatol 2004; 31:1738-45.
31. Kirwan JR, Hewlett S, Cockshott Z, Barrett J. Clinical and psychological outcomes of patient education in rheumatoid arthritis. Musculoskeletal Care 2005;3:1-16.
32. Giraudet-Le Quintrec J-S, Mayoux-Benhamou M, Ravoud P et al. Effect of a collective educational program for patients with rheumatoid arthritis: a prospective 12-month randomized controlled trial. J Rheumatol 2007; 34:1684-91.
33. Masiero S, Boniolo A, Wassermann L, Machiedo H, Volante D, Punzi L. Effects of an educational-behavioural joint protection program on people with moderate to severe rheumatoid arthritis; a randomised controlled trial. Clin Rheumatol 2007;26:2043-50.
34. Hill J, Bird H, Johnson S. Effect of patient education on adherence to drug treatment for rheumatoid arthritis: a randomised controlled trial. Ann Rheum Dis 2001;60: 869-75.
35. Freeman K, Hammond A, Lincoln NB. Use of cognitive-behavioural arthritis education programmes in newly diagnosed rheumatoid arthritis. Clin Rehabil 2002; 16:828-36.
36. Nunez M, Nunez E, Yoldi C, Quinto L, Hernandez MV, Munoz-Gomez J. Health-related quality of life in rheumatoid arthritis: therapeutic education plus pharmacological treatment versus pharmacological treatment only. Rheumatol Int 2006;26:752-7.
37. Abourazzak F, El Mansouri L, Huchet D et al. Long-term effects of therapeutic education for patients with rheumatoid arthritis. Joint Bone Spine 2009;76:648-53.
38. Lovisi Neto BE, Jennings F, Barros Ohashi C, Silva PG, Natour J. Evaluation of the efficacy of an educational program for rheumatoid arthritis patients. Clin Exp Rheumatol 2009;27:28-34.
39. Mulligan K, Newman S. Psychoeducational intervention in rheumatic diseases: a review of papers published from September 2001 to August 2002. Curr Opin Rheum 2003;15:156-9.
40. Marteau T, Dieppe P, Foy R, Kinmonth AL, Schneiderman N. Behavioural medicine: changing our behaviour. Br Med J 2006;332:437-8.
41. Iversen MD, Hammond A, Betteridge N. Self-management of rheumatic diseases; state of the art and future perspectives. Ann Rheum Dis 2010;69:955-63.
42. Taal E, Rasker JJ, Weigman O. Patient education and self-management in the rheumatic diseases: a self-efficacy approach. Arthritis Care Res 1996;9: 229-38.
43. Bandura A. Self-efficacy: toward a unifying theory of behavioural change. Psychol Rev 1977;84:191-215.
44. John H, Hale ED, Treharne GJ, Carroll D, Kitas GD. 'Extra information a bit further down the line': patient perceptions of developing patient education material about the cardiovascular aspects of rheumatoid arthritis. Musculoskeletal Care 2009;7:272-87.
45. Brus HLM, van de Laar MA, Taal E, Rasker JJ, Weigman O. Compliance in rheumatoid arthritis and the role of formal patient education. Semin Arthritis Rheum 1997;26:702-10.
46. Warsi A, LaValley MP, Wang PS, Avorn J, Solomon DH. Arthritis self-management education programs: a meta-analysis of the effect on pain and disability. Arthritis Rheum 2003;48:2207-13.
47. Ramos-Remus C, Salcedo-Rocha AL, Prieto-Parra RE, Galvan-Villegas F. How important is patient education? Baillieres Best Pract Res Clin Rheumatol 2000;14: 689-703.
48. Felson DT, Anderson JJ, Boers M et al. American College of Rheumatology: preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
49. Summers GD, Metsios G, Stavropoulos-Kalinoglou A, Kitas GD. Rheumatoid cachexia and cardiovascular disease. Nat Rev Rheumatol 2010;6:445-51.
50. Whittemore R, Melkus G, Wagner J, Northrup V, Dziura J, Grey M. Translating the diabetes prevention programme to primary care: a pilot study. Nurse Res 2009;58:2-12.
51. Giannuzzi P, Temporelli PL, Marchioli R et al. Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network. Arch Intern Med 2008; 168:2194-204.
52. Tonstad S, Soderblom Alm C, Sandvik E. Effect of nurse counselling on metabolic risk factors in patients with mild hypertension: a randomised controlled trial. Eur J Cardiovasc Nurs 2007;6:160-4.
53. Bruckert E, Giral P, Paillard F et al. Effect of an educational programme (PEGASE) on cardiovascular risk in hypercholesterolaemic patients. Cardiovasc Drugs Ther 2008;22: 495-505.
54. Eriksson MK, Franks PW, Eliasson M. A 3-year randomized trial of lifestyle intervention for cardiovascular risk reduction in the primary care setting: the Swedish Bjorknas study. PLoS One 2009;4:e5197.
55. Skinner TC, Carey ME, Cradock S et al. Diabetes education and self-management for ongoing and newly diagnosed (DESMOND): process modelling of pilot study. Patient Educ Couns 2006;64:369-77.
56. Kirwan JR. Patient education in rheumatoid arthritis. Curr Opin Rheumatol 1990;2:336-9.
57. Clifford RM, Davis WA, Batty KT, Davis TM. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 2005;28:771-6.
58. Edelman D, Oddone EZ, Libowitz RS et al. A multidimensional integrative medicine intervention to improve cardiovascular risk. J Gen Intern Med 2006;21:734.
59. Redfern J, Briffa T, Ellis E, Freedman SB. Choice of secondary prevention improves risk factors after acute coronary syndrome: 1-year follow-up of the CHOICE (Choice of Health Options In prevention of Cardiovascular Events) randomised controlled trial. Heart 2009;95:468-75.
60. Janssen PGH, Gorter KJ, Stolk RP, Rutten GEHM. Randomised controlled trial of intensive multifactorial treatment for cardiovascular risk in patients with screen-detected type 2 diabetes: 1-year data from the ADDITION Netherlands study. Br J Gen Pract 2009;59: 43-8.
61. Jelinek M, Vale MJ, Liew D et al. The COACH program produces sustained improvements in cardiovascular risk factors and adherence to recommended medications -two years follow up. Heart Lung Circ 2009;18:388-92.
62. Southard BH, Southard DR, Nuckolls J. Clinical trial of an Internet-based case management system for secondary prevention of heart disease. J Cardiopulm Rehabil 2003; 23:341-8.
63. Davies MJ, Heller S, Skinner TC et al. Effectiveness of the diabetes education and self management programme for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. Br Med J 2008;336:491-5.
64. Vestfold Heartcare Study Group. Influence on lifestyle measures and five-year coronary risk by a comprehensive lifestyle intervention programme in patients with coronary heary disease. Eur J Cardiovasc Prev Rehabil 2003;10: 429-37.
65. Reid RD, Dafoe WA, Morrin L et al. Impact of program duration and contact frequency on efficacy and cost of cardiac rehabilitation: results of a randomized trial. Am Heart J 2005;149:862-8.
66. Giallauria F, Lucci R, D'Agostino M et al. Two-year multicomprehensive secondary prevention program: favourable effects in cardiovascular functional capacity andcoronary risk profile after acute myocardial infarction. J Cardiovasc Med 2009;10:772-80.
67. Jiang X, Sit JW, Wong TK. A nurse-led cardiac rehabilitation programme improves health behaviours and cardiac physiological parameters: evidence from Chengdu, China. J Clin Nurs 2007;16:1886-97.
68. Kjelsberg MO, Cutler JA, Dolecek TA. Brief description of the Multiple Risk Factor Intervention Trial. Am J Clin Nutr 1997;65(Suppl. 1):191S-95S.
69. Ebrahim S, Beswick A, Burke M, Davey Smith G. Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database Syst Rev 2006;18: CD001561.
70. Rachmani R, Slavachevski I, Berla M, Frommer-Shapira R, Ravid M. Teaching and motivating patients to control their risk factors retards progression of cardiovascular as well as microvascular sequelae of type 2 diabetes mellitus. Diabet Med 2005;22:410-14.
71. Jolliffe J, Rees K, Taylor RSS, Thompson DR, Oldridge N, Ebrahim S. Exercise-based rehabilitation for coronary heart disease. Cochrane Database Syst Rev 2001;1: CD001800.
72. Ockene IS, Hayman LL, Pasternak RC, Schron E, Dunbar-Jacob J. Task force '4-adherence issues and behaviour changes: achieving a long-term solution. 33rd Bethesda Conference. J Am Coll Cardiol 2002;40:630-40.
73. John H, Hale ED, Treharne GJ, Carroll D, Kitas GD. "All singing from the same hymn sheet": healthcare professionals' perceptions of developing patient education material about the cardiovascular aspects of rheumatoid arthritis. Musculoskeletal Care 2009;7: 256-71.
74. Welschen LM, Bot SD, Dekker JM, Timmermans D, van der Weijden T, Nijpels G. The @RISK study: risk communication for patients with type 2 diabetes: design of a randomised controlled trial. BMC Public Health 2010;10:457.
75. Prochaska JO, Diclemente CC, Norcross JC. In search of how people change. Applications to addictive behaviors. Am Psychol 1992;47:1102-14.
76. van der Weijden T, van Steenkiste B, Stoffers HE, Timmermans D, Grol R. Primary prevention of cardiovascular diseases in general practice: mismatch between cardiovascular risk and patients' risk perceptions. Med Decis Making 2007;27:754-61.
77. van Steenkiste B, van der Weijden T, Timmermans D, Vaes J, Stoffers J, Grol R. Patients' ideas, fears and expectations of their coronary risk: barriers for primary prevention. Patient Educ Couns 2004;55:301-7.
78. Rubak S, Sandbaek A, Lauritzen T, Christensen B. Motivational interviewing: a systematic review and meta-analysis. Br J Gen Pract 2005;55:305-12.
79. Irwin MR, Davis M, Zautra A. Behavioural comorbidities in rheumatoid arthritis: a psychoneuroimmunological perspective. Psychiatr Times 2008;25:1.
80. Green T, Haley E, Eliasziw M, Hoyte K. Education in stroke prevention: efficacy of an educational counselling intervention to increase knowledge in stroke survivors. Can J Neurosci Nurs 2007; 29:13-20.
81. Hall FC, Dalbeth N. Disease modification and cardiovascular risk reduction: two sides of the same coin? Rheumatology 2005;44:1473-82.
82. Wilcox S, Der Ananian C, Abbott J et al. Perceived exercise barriers, enablers, and benefits among exercising and nonexercising adults with arthritis: results from a qualitative study. Arthritis Rheum 2006;55:616-27.
83. Metsios G, Stavropoulos-Kalinoglou A, Sandoo A et al. Vascular function and inflammation in rheumatoid arthritis: the role of physical activity. Open Cardiovasc Med J 2010; 23:89-96.
84. de Jong Z, Munneke M, Zwinderman AH et al. Is a long-term high-intensity exercise program effective and safe in patients with rheumatoid arthritis? Results of a randomised controlled trial. Arthritis Rheum 2003;48: 2415-24.
85. Gyurcsik NC, Estabrooks PA, Frahm-Templar MJ. Exercise-related goals and self-efficacy as correlates of aquatic exercise in individuals with arthritis. Arthritis Rheum 2003;49:306-13.
86. Der Ananian C, Wilcox S, Saunders R, Watkins K, Evans A. Factors that influence exercise among adults with arthritis in three activity levels. Prev Chronic Dis 2006;3: A81.
87. John H, Treharne GJ, Hale ED, Panoulas VF, Carroll D, Kitas GD. Development and initial validation of a heart disease knowledge questionnaire for people with rheumatoid arthritis. Patient Educ Couns 2009;77:136-43.
88. Etter JF, Bergman MM, Humair JP, Perneger TV. Development and validation of a scale measuring self-efficacy of current and former smokers. Addiction 2000;95:901-13.
89. Birkett NJ, Hotz SB. A self-efficacy scale for heart-healthy eating. Can J Public Health 1994;85:201-4.
90. Clark MM, Abrams DB, Niaura RS, Eaton CA, Rossi JS. Self-efficacy in weight management. J Consult Clin Psychol 1991;59:739-44.
91. Schwarzer R, Renner B. Health-specific self-efficacy scales. http://userpage.fu-berlin.de/-health/healself.pdf (18 October 2009, date last accessed).
92. Prochaska JO, Velicer WF, Redding C et al. Stage-based expert systems to guide a population of primary care patients to quit smoking, eat healthier, prevent skin cancer, and receive regular mammograms. Prev Med 2005;41: 406-16.
93. Adebajo A, Blenkiron L, Dieppe P. Patient education for diverse populations. Rheumatology 2004;43:1321-2.
94. Buchbinder R, Hall S, Youd JM. Functional health literacy of patients with rheumatoid arthritis attending a community-based rheumatology practice. J Rheumatol 2006;33:879-86.
95. Evers A, Kraaimaat FW, Geenen R, Bijlsma JW. Psychosocial predictors of functional change in recently diagnosed rheumatoid arthritis patients. Behav Res Ther 1998;36:179-93.
96. Hippisley-Cox J, Coupland C, Vinogradova Y et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. Br Med J 2008;336:1475-82.